Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.

R. Ohno; S. Yokomaku; M. Okumara; M. Tanimoto; Y. Morishita; Y. Morishima; Y. Kodera; H. Saito

doi:10.1007/978-3-642-74643-7_55

Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.

R. Ohno, S. Yokomaku, M. Okumara, M. Tanimoto, Y. Morishita, Y. Morishima, Y. Kodera, H. Saito

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	304-308
Number of pages	5
Journal	Haematology and blood transfusion
Volume	33
DOIs	https://doi.org/10.1007/978-3-642-74643-7_55
Publication status	Published - 1990
Externally published	Yes

Access to Document

10.1007/978-3-642-74643-7_55

Cite this

Ohno, R., Yokomaku, S., Okumara, M., Tanimoto, M., Morishita, Y., Morishima, Y., Kodera, Y., & Saito, H. (1990). Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia. Haematology and blood transfusion, 33, 304-308. https://doi.org/10.1007/978-3-642-74643-7_55

Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia. / Ohno, R.; Yokomaku, S.; Okumara, M. et al.
In: Haematology and blood transfusion, Vol. 33, 1990, p. 304-308.

Research output: Contribution to journal › Article › peer-review

Ohno, R, Yokomaku, S, Okumara, M, Tanimoto, M, Morishita, Y, Morishima, Y, Kodera, Y & Saito, H 1990, 'Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.', Haematology and blood transfusion, vol. 33, pp. 304-308. https://doi.org/10.1007/978-3-642-74643-7_55

Ohno R, Yokomaku S, Okumara M, Tanimoto M, Morishita Y, Morishima Y et al. Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia. Haematology and blood transfusion. 1990;33:304-308. doi: 10.1007/978-3-642-74643-7_55

Ohno, R. ; Yokomaku, S. ; Okumara, M. et al. / Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia. In: Haematology and blood transfusion. 1990 ; Vol. 33. pp. 304-308.

@article{6ab77887a338411aac8787bdf3a28718,

title = "Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.",

author = "R. Ohno and S. Yokomaku and M. Okumara and M. Tanimoto and Y. Morishita and Y. Morishima and Y. Kodera and H. Saito",

year = "1990",

doi = "10.1007/978-3-642-74643-7_55",

language = "English",

volume = "33",

pages = "304--308",

journal = "Haematology and blood transfusion",

issn = "0171-7111",

}

TY - JOUR

T1 - Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.

AU - Ohno, R.

AU - Yokomaku, S.

AU - Okumara, M.

AU - Tanimoto, M.

AU - Morishita, Y.

AU - Morishima, Y.

AU - Kodera, Y.

AU - Saito, H.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025178776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025178776&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-74643-7_55

DO - 10.1007/978-3-642-74643-7_55

M3 - Article

C2 - 2182424

AN - SCOPUS:0025178776

SN - 0171-7111

VL - 33

SP - 304

EP - 308

JO - Haematology and blood transfusion

JF - Haematology and blood transfusion

ER -

Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.

Access to Document

Other files and links

Cite this